USF Available Technologies
has recently attracted interest due to its low probability of bacterial resistance compared to other conventional antibiotics. However, hydantoin derivatives generally show only moderate antibacterial activity, which may limit their application.
USF inventors have found a way to enhance the antibacterial activity of hydantoins by adding new components to the central structure of the compounds. These components are cationic groups and lipid tails, which enable the hydantoins to break down bacterial membranes, thus killing the pathogens. In addition, the compounds are able to pass through bacterial membranes and directly act on other targets such as DNA and ribosomes. This dual approach to killing bacteria could lead to a new generation of antibiotics with high potency and novel mechanisms, as well as lower probability of developing resistance. These compounds also show a higher effectiveness compared to standard antibiotics. They will be promising alternatives to killing drug resistant bacteria.
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